Hepatocellular carcinoma: current management and recent advances.
about
Interferon lambda: a new sword in cancer immunotherapyThe Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular CarcinomaQuality of life and hepatocellular carcinomaEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaSuperparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysisNatural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damageThe usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot studyMinimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Radiofrequency ablation of hepatocellular carcinoma: a literature reviewRadiofrequency ablation of hepatocellular carcinoma: Current statusPredicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinomaEffect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patientsRepeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review.Development and validation of a prediction score for complications after hepatectomy in hepatitis B-related hepatocellular carcinoma patients.Hepatocellular Carcinoma Presenting with Obstructive Jaundice during PregnancyThe role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.Acetaldehyde adducts in alcoholic liver disease.Role of MicroRNAs in Hepatocellular CarcinomaHepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaLongterm follow-up after transarterial chemotherapy for hepatocellular carcinoma in a Scandinavian centre.Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinomaHigh expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinomaClinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)Transcatheter arterial chemoembolization: history for more than 30 years.Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transitionPrognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinomaQuantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion.Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study.Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patientsHistone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre.Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
P2860
Q21296797-4CB17F2A-7FD3-47BE-8EBC-47D6F0B0081EQ26764896-AF9AB425-1B8D-4479-9DA9-09D3D67EE07FQ26825504-F46F370A-639B-4E27-8E37-CD7FBA2C6127Q26849546-7F180E1E-773E-4C22-A71D-064BB58ECCF4Q28082299-C39231DD-9DCF-4E0D-9B94-E275C534D7C7Q28488280-1E5707BA-DFA5-4B02-9E42-88D71CE112C9Q30407178-06916BEB-226A-49EB-B286-538E4ED7624CQ30468280-14DE3C0B-3707-4F3D-BE4B-D39B41FEE705Q30473747-A015D7AA-8664-408B-A123-D6E7C288D16AQ30478030-9C7C783F-662F-4EFC-BE0B-18EC5DE44C9FQ33514753-C8EC1FC9-FFDB-4946-8A43-B149316AAAF5Q33646315-2064BDD4-3FA2-4840-9BB0-517E9D422A8CQ33858532-9BBBB6DB-6094-4170-BA30-C97FFF53A02FQ33977186-D3EFFD5C-732C-4D05-8AB5-71785A0DF5C7Q33995733-3B6E5ADC-FEEF-4E69-BB32-0E8FAB880828Q34050844-74FABD9B-E08B-4278-A129-18135DB11E2BQ34069618-272C32F2-A236-4A85-9E72-BCC47BF1EC3FQ34113485-EB70760F-0F1E-49AB-AA2A-F2774057A322Q34185763-326297CC-B260-426F-91E5-0792FBD45007Q34348824-CEF57871-7EEF-48CE-8B18-2650E3EEEC37Q34359262-6FCD4D53-034C-4AD9-9277-F12E7D37EEDAQ34394479-EC2824EA-34F7-4BB1-985D-0A4636D2F383Q34460752-FD6944EA-FB72-4C8F-8424-9C9DE4AE3D40Q34462989-E20C6C80-37F1-430B-AD26-313BB5404B57Q34499336-64BBCFB1-77A5-4436-88E2-C3273F2AF062Q34529319-2AFE23F6-6348-49B5-B7C3-59EE72595669Q34642418-5E036F16-F700-4BA5-8CBF-FE230C5CB9ACQ34932446-1B1F0685-706B-4C8F-8116-05643B3E2FD4Q35158760-10493DE8-3A7B-40B0-8642-E185979AC0C2Q35221816-0F0E008C-343E-4321-A3FA-09BABD677CC8Q35568782-F4F297DC-1036-4F20-9CCC-055A50173B5DQ35600888-52B7EAFC-C87A-4640-96B5-5D17E3C6B637Q35721266-4166B97C-280B-4C53-B4D0-E492D6CAF4E8Q35752265-F78E06AD-B0E6-4C2A-9325-73D3266883EBQ35872656-6116429F-F727-46EB-911B-4545512C07DDQ35881832-CF304F7A-207A-49DF-BC69-E83411DBEE4CQ35893218-10AC4B7C-C205-49A7-9247-D1D95629CD59Q36016057-F696440C-0EA9-49AD-B7E2-6D7FBCF6F189Q36020101-39F740E6-8C0F-4CC1-B4B1-CCB9DD741D3CQ36063288-634D96FA-9B4A-4D0F-9250-2979B01342E0
P2860
Hepatocellular carcinoma: current management and recent advances.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma: current management and recent advances.
@en
Hepatocellular carcinoma: current management and recent advances.
@nl
type
label
Hepatocellular carcinoma: current management and recent advances.
@en
Hepatocellular carcinoma: current management and recent advances.
@nl
prefLabel
Hepatocellular carcinoma: current management and recent advances.
@en
Hepatocellular carcinoma: current management and recent advances.
@nl
P1476
Hepatocellular carcinoma: current management and recent advances
@en
P2093
Wan-Yee Lau
P304
P577
2008-06-01T00:00:00Z